Regulation of T-cadherin by hormones, glucocorticoid and EGF

Gene

Volumn 374, Issue 1-2, 2006, Pages 58-67

  Bromhead, Collette ^a,b   Miller, John H ^b   McDonald, Fiona J ^c  

^a Wellington Medical School   (New Zealand)

^b VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cell adhesion; H cadherin; Osteoblasts; Promoter; Real time RT PCR; Transcription

Indexed keywords

ADIPONECTIN; CADHERIN; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR; ESTRADIOL; GLUCOCORTICOID; PROGESTERONE; PROTEIN TRUNCATED CADHERIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA BINDING; DNA FLANKING REGION; DRUG MECHANISM; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM FACTOR; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

5' FLANKING REGION; ANIMALS; CADHERINS; CELL ADHESION; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; CERCOPITHECUS AETHIOPS; COS CELLS; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR; ESTRADIOL; GENE EXPRESSION REGULATION; GENES, REPORTER; GLUCOCORTICOIDS; HORMONES; HUMANS; LUCIFERASES; OSTEOSARCOMA; PROGESTERONE; PROMOTER REGIONS (GENETICS); RNA, MESSENGER;

EID: 33646698010     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2006.01.013     Document Type: Article

References (37)

1. Adachi Y., Takeuchi T., Sonobe H., and Ohtsuki Y. An adiponectin receptor, T-cadherin, was selectively expressed in intratumoral capillary endothelial cells in hepatocellular carcinoma: possible cross talk between T-cadherin and FGF-2 pathways. Virchows Arch. (2005) 1-8
2. Angst B.D., Marcozzi C., and Magee A.I. The cadherin superfamily: diversity in form and function. J. Cell Sci. 114 (2001) 629-641
3. Cavallaro U., Liebner S., and Dejana E. Endothelial cadherins and tumor angiogenesis. Exp. Cell. Res. (2005) (Epub ahead of print)
4. Cheng S.L., et al. Human osteoblasts express a repertoire of cadherins, which are critical for BMP-2-induced osteogenic differentiation. J. Bone Miner. Res. 13 (1998) 633-644
5. Crandall C. Combination treatment of osteoporosis: a clinical review. J. Womens Health Gend. Based Med. 11 (2002) 211-224
6. Fallo F., et al. Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome. Eur. J. Endocrinol. 150 (2004) 339-344
7. Feltus F.A., et al. Epidermal growth factor increases cortisol production and type II beta-hydroxysteroid dehydrogenase/Delta (5)-Delta (4)-isomerase expression in human adrenocortical carcinoma cells: evidence for a Stat5-dependent mechanism. Endocrinology 144 (2003) 1847-1853
8. Fredette B.J., Miller J., and Ranscht B. Inhibition of motor axon growth by T-cadherin substrata. Development 122 (1996) 3163-3171
9. Hadjiargyrou M., et al. Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair. J. Biol. Chem. 277 (2002) 30177-30182
10. Hug C., Wang J., Shezheen Ahmad N.S., Bogan J., Tsao T., and Lodish H.F. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 10308-10313
11. Ibanez L., and de Zeghner F. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperadrogenism: opposite effects on adipocytokines and body adiposity. J. Clin. Endocrinol. Metab. 89 (2005) 1592-1597
12. Jarrard D.F., et al. P-cadherin is a basal cell-specific epithelial marker that is not expressed in prostrate cancer. Clin. Cancer Res. 3 (1997) 2121-2128
13. Jones C.D., Yeung C., and Zehnder J.L. Comprehensive validation of a real-time quantitative bcr-able assay for clinical laboratory use. Am. J. Clin. Pathol. 120 (2003) 42-48
14. Kashima T., et al. Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo. Int. J. Cancer 104 (2003) 147-154
15. Kuzmenko Y.S., Kern F., Bochkov V.N., Tkachuk V.A., and Resink T.J. Density- and proliferation status-dependent expression of T-cadherin, a novel lipoprotein-binding glycoprotein: a function in negative regulation of smooth muscle cell growth?. FEBS Lett. 434 (1998) 183-187
16. Kuzmenko Y.S., Stambolsky D., Kern F., Bochkov V.N., Tkachuk V.A., and Resink T.J. Characteristics of smooth muscle cell lipoprotein binding proteins (p105/p130) as T-cadherin and regulation by positive and negative growth regulators. Biochem. Biophys. Res. Commun. 246 (1998) 489-494
17. Lee S.W. H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat. Med. 2 (1996) 776-782
18. Lenchik L., et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33 (2003) 646-651
19. Niermann T., Kern F., Erne P., and Resink T. The glycosyl phosphatidylinositol anchor of human T-cadherin binds lipoproteins. Biochem. Biophys. Res. Commun. 276 (2000) 1240-1247
20. Niermann T., Schmutz S., Erne P., and Resink T. Aryl hydrocarbon receptor ligands repress T-cadherin expression in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 300 (2003) 943-949
21. Peinado H., Portillo F., and Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol. 48 (2004) 365-375
22. Pfaffl M.W. Quantification strategies in real-time PCR. In: Bustin S.A. (Ed). A-Z of quantitative PCR (2004), International University Line, La Jolla, CA, USA 1-23
23. Ranscht B., and Bronner-Fraser M. T-cadherin expression alternates with migrating neural crest cells in the trunk of the avian embryo. Development 111 (1991) 15-22
24. Ranscht B., and Dours-Zimmermann M.T. T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region. Neuron 7 (1991) 391-402
25. Ringwald M., et al. The structure of cell adhesion molecule uvomorulin: insights into the molecular mechanism of Ca2+-dependent cell adhesion. EMBO J. 6 (1987) 3647-3653
26. Rubina K., et al. LDL induces intracellular signalling and cell migration via atypical LDL-binding protein T-cadherin. Mol. Cell. Biochem. 273 (2005) 33-41
27. Sato M., Mori Y., Sakurada A., Fujimura S., and Horii A. The H-cadherin (CDH13) gene is inactivated in human lung cancer. Hum. Genet. 103 (1998) 96-101
28. Takeuchi T., et al. Expression of T-cadherin (CDH13, H-cadherin) in human brain and its characteristics as a negative growth regulator of epidermal growth factor in neuroblastoma cells. J. Neurochem. 74 (2000) 1489-1497
29. Takeuchi T., Misaki A., Sonobe H., Liang S.B., and Ohtsuki Y. Is T-cadherin (CDH13, H-cadherin) expression related to lung metastasis of osteosarcoma?. Histopathology 37 (2000) 193-194
30. Takeuchi T., and Ohtsuki Y. Recent progress in T-cadherin (CDH13 H-cadherin) research. Histol. Histopathol. 16 (2001) 1287-1293
31. Thway T.M., and Wolfe M.W. An activator protein-1 complex mediates epidermal growth factor regulation of equine glycoprotein alpha subunit expression in trophoblast cells. Biol. Reprod. 67 (2002) 972-980
32. Toyooka S., et al. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res. 62 (2002) 3382-3386
33. Vandesompele J., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 (2002) 0034.1-0034.11
34. Vestal D.J., and Ranscht B. Glycosyl phosphatidylinositol-anchored T-cadherin mediates calcium-dependent, homophilic cell adhesion. J. Cell Biol. 119 (1992) 451-461
35. Wang Y.N., and Chang W.C. Induction of disease-associated keratin 16 gene expression by epidermal growth factor is regulated through cooperation of transcription factors Sp1 and c-Jun. J. Biol. Chem. 278 (2003) 45848-45857
36. Whyte D.A., et al. Ksp-cadherin gene promoter: I. Characterisation and renal epithelial cell-specific activity. Am. J. Physiol. 277 (1999) F587-F598
37. Zucchini C., et al. Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene. Bone 34 (2004) 672-679